Skip to main content
. 2021 Feb 24;15:1753466621995048. doi: 10.1177/1753466621995048

Table 2.

Changes in clinical parameters.

Variable Baseline Follow-up Change (%) p-value*
Hemodynamics
Mean RAP, mmHg 6.5 (4.0–8.0) 4.0 (3.0–5.0) −2.5 (−38) 0.005
Mean PAP, mmHg 56.0 (46.3–65.5) 40.0 (30.0–47.0) −16.0 (−29) <0.001
PAWP, mmHg 7.5 (6.0–9.8) 9.0 (8.0–11.0) 1.5 (20) 0.68
CO, L/min 3.3 (2.4–4.5) 6.0 (5.1–6.7) 2.7 (82) <0.001
CI, L/min per m2 2.2 (1.7–2.7) 3.8 (3.3–4.5) 1.6 (73) <0.001
PVR, WU 13.5 (8.8–21.5) 4.7 (2.8–6.9) −8.8 (−65) <0.001
Echocardiography
TAPSE, cm 1.5 (1.3–1.8) 2.3 (1.9–2.6) 0.8 (53) 0.001
RVS’, cm 9.7 (7.8–11.8) 13.3 (12.4–14.4) 3.6 (37) 0.001
RAA, cm2 17.2 (14.9–21.3) 16.4 (14.1–21.0) −0.8 (−5) 0.49
RVEDA, cm2 26.9 (22.8–33.1) 24.1 (21.0–30.3) −2.8 (−10) 0.21
RVESA, cm2 20.4 (16.3–23.9) 16.4 (13.8–21.1) −4.0 (−20) 0.006
FAC, % 23.6 (16.2–26.9) 32.9 (29.1–35.8) 9.3 (39) <0.001
WHO-FC
I or II 4 (22) 16 (89)
III or IV 14 (78) 2 (11)
6MWD, m 405.0 (303.0–441.8) 472.0 (439.5–493.5) 67.0 (17) 0.046
BNP, pg/mL 187.8 (36.7–379.5) 17.5 (10.3–27.2) −170.3 (−91) <0.001

Data are expressed as number (%) or median (interquartile range). The number of subjects at baseline and follow-up was the same equal number in each parameter. Eighteen patients were analyzed in hemodynamics, and 20 patients in echocardiography.

*

p-value was calculated using a Wilcoxon’s signed rank test for comparison of baseline and follow-up.

6MWD, 6-minute walk distance; BNP, B-type natriuretic peptide; CI, cardiac index; CO, cardiac output; FAC, fractional area change; PAP, pulmonary arterial pressure; PAWP, pulmonary arterial wedge pressure; PVR, pulmonary vascular resistance; RAA, right atrial area; RAP, mean right atrial pressure; RVEDA, right ventricular end-diastolic area; RVESA, right ventricular end-systolic area; RVS’, right ventricular systolic excursion velocity; TAPSE, tricuspid annular plane systolic excursion; WHO-FC, World Health Organization functional class; WU, Wood units.